Lin Xia
- Cancer Research top 1%
- MicroRNA in disease regulation 10
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 6
- Geriatrics and Gerontology top 5%
- Oncology top 5%
- Molecular Biology top 5%
- Circular RNAs in diseases 6
-
- Immune Cell Function and Interaction 5
-
- Virus-based gene therapy research 5
-
- Gastrointestinal disorders and treatments 5
-
- Ferroptosis and cancer prognosis 5
-
- Monoclonal and Polyclonal Antibodies Research 5
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lin Xia
75 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 1.1k
- Gastroenterology 156
- Geriatrics and Gerontology 98
- Oncology 615
- Molecular Biology 1.5k
Countries citing papers authored by Lin Xia
This map shows the geographic impact of Lin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xia more than expected).
Fields of papers citing papers by Lin Xia
This network shows the impact of papers produced by Lin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xia. The network helps show where Lin Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 55 | |
| 6 | 2021 | 41 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 5 | |
| 9 | 2020 | 207 | |
| 10 | 2020 | 7 | |
| 11 | 2019 | 17 | |
| 12 | Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy | 2015 | 5 |
| 13 | 2014 | 100 | |
| 14 | 2014 | 15 | |
| 15 | 2012 | 35 | |
| 16 | 2012 | 147 | |
| 17 | 2008 | 29 | |
| 18 | A Survival Analysis of Nasopharyngeal Carcinoma from 1995 to 2004 in Sihui,Guangdong | 2007 | 2 |
| 19 | MELT INCLUSIONS IN MAGMATIC ROCKS | 2002 | 2 |
| 20 | Wirkungen von Retinoiden auf Proliferation und Differenzierung humaner Talgdrüsenzellen in einem In-vitro-Modell | 1991 | 1 |
About Lin Xia
Lin Xia is a scholar working on Gastroenterology, Cancer Research and Oncology, having authored 84 papers that have together received 2.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Gastrointestinal Tumor Research and Treatment (6 papers), Circular RNAs in diseases (6 papers), Immune Cell Function and Interaction (5 papers), Virus-based gene therapy research (5 papers), Gastrointestinal disorders and treatments (5 papers), Ferroptosis and cancer prognosis (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Gastroenterology (156 citations) and Geriatrics and Gerontology (98 citations). Lin Xia has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rui Du, Daiming Fan, Shiren Sun, Yanglin Pan, Lina Zhao, Xiaoting Wu, Jie Liu, Liu Hong, Dexin Zhang and Yong Wang. Their work appears in journals such as Oncotarget, Cancer Medicine, International Immunopharmacology, Pharmacological Research and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.